ZIOPHARM Oncology Inc Price to Book Ratio 2006-2021 | ZIOP

Historical price to book ratio values for ZIOPHARM Oncology Inc (ZIOP) over the last 10 years. The current price to book ratio for ZIOPHARM Oncology Inc as of October 15, 2021 is 4.13.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

ZIOPHARM Oncology Inc Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2021-10-15 1.69 4.13
2021-06-30 2.64 $0.41 6.45
2021-03-31 3.60 $0.49 7.33
2020-12-31 2.52 $0.58 4.36
2020-09-30 2.52 $0.68 3.72
2020-06-30 3.28 $0.76 4.30
2020-03-31 2.45 $0.84 2.91
2019-12-31 4.72 $0.52 9.03
2019-09-30 4.28 $0.59 7.30
2019-06-30 5.83 $0.38 15.28
2019-03-31 3.85 $0.46 8.42
2018-12-31 1.87 $0.53 3.52
2018-09-30 3.20 $-1.10 -2.91
2018-06-30 3.02 $-0.98 -3.09
2018-03-31 3.92 $-0.86 -4.53
2017-12-31 4.14 $-0.68 -6.10
2017-09-30 6.14 $-0.56 -10.92
2017-06-30 6.22 $-0.45 -13.74
2017-03-31 6.34 $-0.72 -8.84
2016-12-31 5.35 $-0.58 -9.16
2016-09-30 5.63 $-0.49 -11.51
2016-06-30 5.49 $-0.39 -13.91
2016-03-31 7.42 $0.59 12.57
2015-12-31 8.31 $0.66 12.53
2015-09-30 9.00 $0.72 12.55
2015-06-30 12.00 $0.84 14.21
2015-03-31 10.77 $0.94 11.45
2014-12-31 5.07 $0.32 15.65
2014-09-30 2.64 $0.36 7.43
2014-06-30 4.03 $0.37 10.76
2014-03-31 4.58 $0.41 11.04
2013-12-31 4.34 $0.49 8.80
2013-09-30 3.94 $0.04 90.78
2013-06-30 2.11 $0.23 9.12
2013-03-31 1.83 $0.45 4.04
2012-12-31 4.16 $0.58 7.15
2012-09-30 5.45 $0.74 7.35
2012-06-30 5.95 $0.95 6.26
2012-03-31 5.40 $1.23 4.40
2011-12-31 4.41 $1.03 4.26
2011-09-30 4.41 $1.23 3.59
2011-06-30 6.12 $1.23 4.97
2011-03-31 6.25 $1.24 5.04
2010-12-31 4.66 $0.63 7.39
2010-09-30 3.75 $0.87 4.31
2010-06-30 3.18 $1.12 2.84
2010-03-31 5.08 $0.27 18.61
2009-12-31 2.96 $0.68 4.38
2009-09-30 2.74 $0.15 17.86
2009-06-30 1.63 $0.08 21.17
2009-03-31 0.63 $0.17 3.68
2008-12-31 0.58 $0.31 1.88
2008-09-30 1.69 $0.52 3.27
2008-06-30 2.15 $0.76 2.84
2008-03-31 2.94 $1.04 2.83
2007-12-31 3.54 $1.43 2.48
2007-09-30 3.30 $1.78 1.86
2007-06-30 5.15 $2.11 2.44
2007-03-31 5.11 $2.40 2.13
2006-12-31 5.97 $1.74 3.44
2006-09-30 5.15 $2.09 2.46
2006-06-30 5.20 $2.30 2.26
2006-03-31 4.80 $0.59 8.15
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.364B $0.000B
ZIOPHARM Oncology, Inc. is a biopharmaceutical company engaged in the development and commercialization of a diverse, risk-sensitive portfolio of in-licensed cancer drugs to address unmet medical needs. The Company applies new insights from molecular and cancer biology to understand the efficacy and safety limitations of approved and developmental cancer therapies and identifies proprietary and related molecules for better patient treatment.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $129.683B 8.63
Bio-Rad Laboratories (BIO.B) United States $21.975B 46.83
QIAGEN (QGEN) Netherlands $11.773B 19.94
Biohaven Pharmaceutical Holding (BHVN) United States $8.738B 0.00
Emergent Biosolutions (EBS) United States $2.722B 6.57
Arcus Biosciences (RCUS) United States $2.455B 0.00
Myovant Sciences (MYOV) United Kingdom $1.915B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.755B 0.00
Zymeworks (ZYME) Canada $1.208B 0.00
Ambrx Biopharma (AMAM) United States $0.470B 0.00
SQZ Biotechnologies (SQZ) United States $0.342B 0.00
Enzo Biochem (ENZ) United States $0.183B 18.00